Measles-containing-vaccine first-dose (MCV1) immunization coverage in Lithuania
Lithuania: Measles-containing-vaccine first-dose (MCV1) immunization coverage was 86.0% in 2025. ▼ Falling
Measles-containing-vaccine first-dose (MCV1) immunization coverage in Lithuania, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
In 2025, measles-containing-vaccine first-dose (mcv1) immunization coverage in Lithuania stood at 86.0%. That is the lowest value across all 26 years on record.
That represents a change of down 8.5% over ten years.
Over the whole period, measles-containing-vaccine first-dose (mcv1) immunization coverage in Lithuania peaked at 98.0% in 2002 and was at its lowest, 86.0%, in 2024.
That places Lithuania 121st out of 194 countries with data for 2025, putting it in the middle of the range.
The long-run direction has been consistently falling across the 26 years of available data.
Measles-containing-vaccine first-dose (MCV1) immunization coverage in Lithuania, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 97.0% | — |
| 2001 | 97.0% | +0.0% |
| 2002 | 98.0% | +1.0% |
| 2003 | 98.0% | +0.0% |
| 2004 | 98.0% | +0.0% |
| 2005 | 97.0% | -1.0% |
| 2006 | 97.0% | +0.0% |
| 2007 | 97.0% | +0.0% |
| 2008 | 97.0% | +0.0% |
| 2009 | 96.0% | -1.0% |
| 2010 | 96.0% | +0.0% |
| 2011 | 94.0% | -2.1% |
| 2012 | 93.0% | -1.1% |
| 2013 | 93.0% | +0.0% |
| 2014 | 93.0% | +0.0% |
| 2015 | 94.0% | +1.1% |
| 2016 | 94.0% | +0.0% |
| 2017 | 94.0% | +0.0% |
| 2018 | 92.0% | -2.1% |
| 2019 | 93.0% | +1.1% |
| 2020 | 90.0% | -3.2% |
| 2021 | 88.0% | -2.2% |
| 2022 | 87.0% | -1.1% |
| 2023 | 87.0% | +0.0% |
| 2024 | 86.0% | -1.1% |
| 2025 | 86.0% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 97.2% | 96.0% | 98.0% | 10 |
| 2010s | 93.6% | 92.0% | 96.0% | 10 |
| 2020s | 87.3% | 86.0% | 90.0% | 6 |
Countries ranked near Lithuania
More health data for Lithuania
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.4537 % change on previous year (2090)
- Heat deaths vs projected death rates 1,909 (2090)
- Un projection of annual infant deaths 5 (2100)
- Population ages 65 and above, total, annual growth rate 2.77 % change on previous year (2025)
- Population ages 65 and above, total, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 65 and above, total, per capita 0.2072 units per person (2025)
- Population, female, annual growth rate -0.0308 % change on previous year (2025)
- Population, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population, female, per capita 0.5278 units per person (2025)
Frequently asked questions
- What is measles-containing-vaccine first-dose (mcv1) immunization coverage in Lithuania?
- Measles-containing-vaccine first-dose (mcv1) immunization coverage in Lithuania was 86.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest measles-containing-vaccine first-dose (mcv1) immunization coverage recorded in Lithuania?
- The highest recorded value was 98.0% in 2002.
- What is the lowest measles-containing-vaccine first-dose (mcv1) immunization coverage recorded in Lithuania?
- The lowest recorded value was 86.0% in 2024.
- How does Lithuania rank for measles-containing-vaccine first-dose (mcv1) immunization coverage?
- Lithuania ranks 121st out of 194 countries with data for 2025.
- Is measles-containing-vaccine first-dose (mcv1) immunization coverage rising or falling in Lithuania?
- Over the last ten years it is down 8.5%. The long-run trend across the full record is falling.
- Where does this Lithuania data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Measles-containing-vaccine first-dose (MCV1) immunization coverage among 1-year-olds (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).